44 Wealth Management LLC Sells 732 Shares of Humana Inc. (NYSE:HUM)

44 Wealth Management LLC lowered its position in shares of Humana Inc. (NYSE:HUM) by 30.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,671 shares of the insurance provider’s stock after selling 732 shares during the period. 44 Wealth Management LLC’s holdings in Humana were worth $424,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in HUM. FNY Investment Advisers LLC lifted its stake in shares of Humana by 6,647.5% in the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock valued at $6,916,000 after acquiring an additional 26,856 shares during the last quarter. Retirement Systems of Alabama lifted its stake in shares of Humana by 735.9% in the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock valued at $55,563,000 after acquiring an additional 192,801 shares during the last quarter. PDT Partners LLC lifted its stake in shares of Humana by 190.0% in the 3rd quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock valued at $1,286,000 after acquiring an additional 2,660 shares during the last quarter. Secure Asset Management LLC bought a new stake in shares of Humana in the 4th quarter valued at about $244,000. Finally, Ontario Teachers Pension Plan Board lifted its stake in shares of Humana by 6.5% in the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock valued at $371,705,000 after acquiring an additional 71,910 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on HUM. Wells Fargo & Company lowered their target price on Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research note on Monday, November 4th. JPMorgan Chase & Co. lowered their target price on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research note on Tuesday, February 18th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $290.00 price target on shares of Humana in a research report on Wednesday, February 12th. Truist Financial upped their price target on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research report on Monday, January 6th. Finally, Morgan Stanley lowered their price target on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 12th. Nineteen investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, Humana has a consensus rating of “Hold” and a consensus target price of $285.68.

Insider Buying and Selling

In related news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.32% of the stock is currently owned by company insiders.

Humana Stock Down 5.7 %

HUM stock opened at $255.77 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The company has a market capitalization of $30.80 billion, a price-to-earnings ratio of 25.71, a price-to-earnings-growth ratio of 2.05 and a beta of 0.56. The business’s 50 day moving average price is $269.41 and its two-hundred day moving average price is $290.00. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46.

Humana (NYSE:HUM) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.38%. Humana’s payout ratio is currently 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.